Silhouette

Brenton Scott

Pulmotect, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate ...
Pulmotect, Inc.
Principal Investigator
HHS 2 $999K 05/01/17 04/30/18
Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate ...
Pulmotect, Inc.
Principal Investigator
HHS 2 $999K 05/01/16 04/30/17
Preventing and treating RSV pneumonia in immunocompromised cancer patients
Pulmotect, Inc.
Principal Investigator
HHS 2 $999K 03/01/16 02/28/17
Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate ...
Pulmotect, Inc.
Principal Investigator
HHS 2 $982K 05/01/15 04/30/16
Preventing asthma exacerbations by reducing viral respiratory infections
Pulmotect, Inc.
Principal Investigator
HHS 2 $986K 08/01/14 07/31/15
Boosting the innate immune system of the lungs to prevent and treat respiratory v
Pulmotect, Inc.
Principal Investigator
HHS 1 $208K 02/06/14 02/05/15
Rapidly boosting innate immunity in the lungs to protect against pneumonia
Pulmotect, Inc.
Principal Investigator
HHS 2 $308K 01/01/14 12/31/14
Rapidly boosting innate immunity in the lungs to protect against pneumonia
Pulmotect, Inc.
Principal Investigator
HHS 2 $998K 01/15/13 12/31/13
Preventing asthma exacerbations by reducing viral respiratory infections
Pulmotect, Inc.
Principal Investigator
HHS 1 $301K 09/01/12 08/31/13
Rapidly boosting innate immunity in the lungs to protect against pneumonia
Pulmotect, Inc.
Principal Investigator
HHS 1 $222K 02/01/11 01/31/12